We are live on ! Find out more
EVOK

Evoke Pharma
EVOK

Delisted

EVOK was delisted on the 16th of December, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of EVOK yet.

EVOK Hedge Fund Activity: Q4 2025 in Review

0 of the 8,245 institutional investors tracked by Wall St. Rank reported a position in Evoke Pharma (EVOK) for Q4 2025, worth a combined $0 — down 100% from $2.94M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of EVOK and 0 opened new positions — a net loss of 15 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Morgan Stanley, exiting entirely with an estimated $792K sold.

  • 0 institutional investors held Evoke Pharma (EVOK) as of Q4 2025, down from 15 in Q3 2025.
  • Funds reported $0 of Evoke Pharma stock for Q4 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Evoke Pharma positions in Q4 2025 and 15 closed out, a net change of -15 holders.
  • The largest Evoke Pharma seller in Q4 2025 was Morgan Stanley, an estimated $792K sold.

Based on aggregated 13F filings for Q4 2025.